Genome-wide association analyses define pathogenic signaling pathways and prioritize drug targets for IgA nephropathyKrzysztof Kiryluk, Dmitry Samsonov, Daniel Cattran et al.|Nature Genetics|2023Cited by 187
Is there long-term value of pathology scoring in immunoglobulin A nephropathy? A validation study of the Oxford Classification for IgA Nephropathy (VALIGA) updateRosanna Coppo, Raffaella Cravero, Graziella D’Arrigo et al.|Nephrology Dialysis Transplantation|2018Cited by 112
Development and testing of an artificial intelligence tool for predicting end-stage kidney disease in patients with immunoglobulin A nephropathyFrancesco Paolo Schena, Harm Peters, Vito Walter Anelli et al.|Kidney International|2020Cited by 110
Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohortRosanna Coppo, Eva Honsová, Danilo Lofaro et al.|Pediatric Nephrology|2016Cited by 93
Tonsillectomy in a European Cohort of 1,147 Patients with IgA NephropathyJohn Feehally, Rosanna Coppo, Stéphan Troyanov et al.|The Nephron journals/Nephron journals|2015Cited by 92